1,723 results on '"Tura, S"'
Search Results
2. SIE-SIES-GITMO Guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias
3. Clinical Study with Human Recombinant Interferon-α2a in Chronic Myeloid Leukemia. Protocol of the Italian Cooperative Study Group on Chronic Myeloid Leukemia: Preliminary Analysis of Results
4. Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines
5. Recombinant Human Erythropoietin After Bone Marrow Transplantation — A Placebo Controlled Trial
6. Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making
7. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow
8. Consensus-based definition of unfitness to intensive and nonintensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making
9. Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis
10. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study
11. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation
12. Pulsed ATRA as single therapy restores long-term remission in PML-RARα-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study
13. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients
14. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients
15. Posttransplant Lymphoproliferative Disorders in Liver Transplanted Patients: A Report of Four Cases
16. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells
17. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
18. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy
19. Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia
20. Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets
21. Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures
22. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells
23. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study
24. Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods
25. Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency
26. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells
27. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
28. Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase
29. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells
30. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate
31. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey
32. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on ‘in vitro’ growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors
33. Low doses of rIL2 after autologous bone marrow transplantation induce a “prolonged” immunostimulation of NK compartment in high-grade non-Hodgkin's lymphomas
34. Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity
35. Interferon in chronic myeloid leukemia: A workshop report
36. Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors
37. Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy
38. Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma
39. Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas
40. Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)
41. Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report
42. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma
43. Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients
44. Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres
45. Recombinant Human Erythropoietin After Bone Marrow Transplantation — A Placebo Controlled Trial
46. Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
47. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients
48. Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation
49. EVALUATION OF THE PRESERVATION STATE OF HISTORICAL PENINSULA IN ISTANBUL BASED ON GEOSPATIAL DATA
50. Randomized trial of 8-week versus 12-week VNCOP-B plusG-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin’s lymphoma patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.